Abstract
Control of cell proliferation and differentiation by the retinoblastoma protein (pRb) depends on its interactions with key cellular substrates. Available data indicate that pRb and the transcription factor Pax 8 play a crucial role in the differentiation of thyroid follicular cells. In this study, we show that pRb takes part in the complex assembled on the thyroperoxidase gene promoter acting as a transcriptional coactivator of Pax 8. Accordingly, pRb interacts with and potentiates Pax 8 transcriptional activity. In addition, we show that the downregulation of pRb gene expression, in thyrocytes, through RNA interference results in a reduction of the thyroperoxidase gene promoter activity mediated by the Pax 8-binding site. In agreement with these results and with the ability of the adenoviral protein E1A to bind pRb, we show that E1A downregulates Pax 8 activity and that such inhibition requires the E1A–Rb interaction. Furthermore, we show that the Pax 8/pRb synergy plays a role on the sodium/iodide symporter gene expression as well.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams PD . (2001). Biochim. Biophys. Acta, 1471, M123–M133.
Ambesi-Impiombato FS, Parks LAM and Coon HG . (1980). Proc. Natl. Acad. Sci. USA, 77, 3455–3459.
Berlingieri MT, Santoro M, Battaglia C, Greco M and Fusco A . (1993). Oncogene, 8, 249–255.
Brummelkamp TR, Bernards R and Agami R . (2002). Science, 296, 550–553.
Chan HM, Krstic-Demanacoes M, Smith L, Demonacos C and La Thangue NB . (2001). Nat. Cell Biol., 3, 667–674.
Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC and Nevins JR . (1992). Proc. Natl. Acad. Sci. USA, 89, 4549–4553.
Chen PL, Riley DJ, Chen Y and Lee WH . (1996a). Genes Dev., 10, 2794–2804.
Chen PL, Riley DJ, Chen-Kiang S and Lee WH . (1996b). Proc. Natl. Acad. Sci. USA, 93, 465–469.
Civitareale D, Castelli MP, Falasca P and Saiardi A . (1993). Mol. Endocrinol., 7, 1589–1595.
Civitareale D, Lonigro R, Sinclair AJ and Di Lauro R . (1989). EMBO J., 8, 2537–2542.
Decary S, Decesse JT, Ogryzko V, Reed JC, Naguibneva I, Harel-Bellan A and Cremisi CE . (2002). Mol. Cell. Biol., 22, 7877–7888.
Decesse JT, Medjkane S, Datto MB and Cremisi CE . (2001). Oncogene, 20, 962–971.
De Leo R, Miccadei S, Zammarchi E and Civitareale D . (2000). J. Biol. Chem., 275, 34100–34105.
Di Palma T, Nitsch R, Mascia A, Nitsch L, Di Lauro R and Zannini M . (2003). J. Biol. Chem., 278, 3395–3402.
Dorfler P and Busslinger M . (1996). EMBO J., 15, 1971–1982.
Eberhard D and Busslinger M . (1999). Cancer Res. (Suppl.), 59, 1716–1725.
Esposito C, Miccadei S, Saiardi A and Civitareale D . (1998). Biochem. J., 331, 37–40.
Fabbro D, Pellizzari L, Mercuri F, Tell G and Damante G . (1998). J. Mol. Endocrinol., 21, 347–354.
Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P, Pritchard LL and Harel-Bellan A . (2001). EMBO Rep., 2, 794–799.
Goodman RH and Smolik S . (2000). Genes Dev., 14, 1553–1577.
Grana X, Garriga J and Mayol X . (1998). Oncogene, 17, 3365–3383.
Harbour JW and Dean DC . (2000). Genes Dev., 14, 2393–2409.
Ho SN, Hunt HD, Horton RM, Pullen JK and Pease LR . (1989). Gene, 77, 51–57.
Iuliano R, Trapasso F, Stella A, Le Pera I, Melillo RM, Bruni P, Baldassarre G, Chiarotti L, Santoro M, Viglietto G and Fusco A . (2000). Exp. Cell. Res., 260, 257–267.
Klenova E, Chernukhin I, Inoue T, Shamsuddin S and Noerton J . (2002). Methods, 26, 254–259.
Lasorella A, Iavarone A and Israel MA . (1996). Mol. Cell. Biol., 16, 2570–2578.
Lipinski MM and Jacks T . (1999). Oncogene, 18, 7873–7882.
Lukas J, Sorensen C, Lukas C, Santoni-Rugiu E and Bartek J . (1999). Oncogene, 18, 3930–3935.
Macchia P, Lapi P, Krude H, Pirro M, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Gruters A, Busslinger M and Di Lauro R . (1998). Nat. Genet., 19, 83–86.
MacLellan WR, Xiao G, Abdellatif M and Schneiter MD . (2000). Mol. Cell. Biol., 20, 8903–8915.
Mansouri A, Chowdhury K and Gruss P . (1998). Nat. Genet., 19, 87–90.
Miccadei S, De Leo R, Zammarchi E, Natali PG and Civitareale D . (2002). Mol. Endocrinol., 16, 837–846.
Miyake S, Sellers WR, Safran M, Li X, Zhao W, Grossman SR, Gan J, DeCaprio J, Adams PD and Kaelin Jr WG . (2000). Mol. Cell. Biol., 20, 8889–8902.
Moran E . (1993). Curr. Opin. Genet Dev., 3, 63–70.
Musti AM, Ursini VM, Avvedimento E, Zimarino V and Di Lauro R . (1987). Nucleic Acid Res., 15, 8149–8166.
Nevins JR . (2001). Hum. Mol. Genet., 10, 699–703.
Ohno M, Zannini M, Lavy O, Carrasco N and Di Lauro R . (1999). Mol. Cell. Biol., 19, 2051–2060.
Pasca di Magliano M, Di Lauro R and Zannini M . (2000). Proc. Natl. Acad. Sci. USA, 93, 465–469.
Perrone L, Pasca di Magliano M, Zannini M and Di Lauro R . (2000). Biochem. Biophys. Res. Commun., 275, 203–208.
Puri PL and Sartorelli V . (2000). J. Cell Physiol., 185, 155–173.
Roberts EC, Deed RW, Inoue T, Norton JD and Sharrocks AD . (2001). Mol. Cell. Biol., 21, 524–553.
Shapiro DJ, Sharp PA, Wahli WW and Keller MJ . (1998). DNA, 7, 47–55.
Sharp PA . (1999). Genes Dev., 13, 139–141.
Sierra J, Villagra A, Paredes R, Cruzat F, Gutirrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, van Wijnen AJ, Lian JB, Stein GS, Stein JL and Montecino M . (2003). Mol. Cell. Biol., 23, 3339–3351.
Suzuki K, Lavaroni S, Mori A, Okajima F, Kimura S, Katoh R, Kawaoi A and Kohn LD . (1998). Mol. Cell. Biol., 18, 7410–7422.
Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC and Hinds PWW . (2001). Cell, 8, 303–316.
Wang JY . (1997). Curr. Opin. Genet. Dev., 7, 39–45.
Weinberg RA . (1995). Cell, 81, 323–330.
Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA and Harlow E . (1988). Nature, 334, 124–129.
Wiggan O, Taniguchi-Sidle A and Hamel PA . (1998). Oncogene, 16, 227–236.
Yuan SS, Yeh YT and Lee E . (2002). Biochem. Biophys. Res. Commun., 296, 1019–1025.
Zannini M, Francis-Lang H, Plachov D and Di Lauro R . (1992). Mol. Cell. Biol., 12, 4230–4241.
Acknowledgements
We thank Thomas Wagner and Armando Felsani for critical reading of the manuscript. Various colleagues kindly provided many of the plasmids used in this study and we thank them for their kindness. The E1A- and E1A-Rb-encoding plasmids were a gift of B Moran (Moran, 1993). pCMV-Rb and pGST-RbLP, pCMV-107 and pCMV-130 were provided by A Felsani e M Caruso. pRbΔcdk was kindly provided by WJ Harbour. We thank MR Nicotra for immunohistochemistry. MM was supported by a fellowship of Marie Curie Training site program number HPMT-CT-2000-0010. This study was in part supported by MURST-FIRB n.RBAU19HHA-001 and by grant no. 210 Life Sciences 2002 from ASI to DC.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Miccadei, S., Provenzano, C., Mojzisek, M. et al. Retinoblastoma protein acts as Pax 8 transcriptional coactivator. Oncogene 24, 6993–7001 (2005). https://doi.org/10.1038/sj.onc.1208861
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208861
Keywords
This article is cited by
-
Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer
Cancer Cell International (2018)
-
PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein
Oncogene (2011)
-
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
Laboratory Investigation (2009)
-
A PANorama of PAX genes in cancer and development
Nature Reviews Cancer (2006)
-
The retinoblastoma tumor-suppressor gene, the exception that proves the rule
Oncogene (2006)